TietoEVRY's EUR 150M Buyback and Dividend Signal Shareholder-Focused Capital Reallocation

The board's recent decisions on listings are best viewed as a disciplined administrative step, not a major capital allocation event. The key financial commitments for shareholders remain the central focus: a dividend of EUR 0.88 per share and a share buyback programme of EUR 150 million. These actions are directly tied to the company's capital allocation principles, specifically connected to the divestment of Bekk Consulting.

The board's choice to keep the Nasdaq Stockholm listing, while proceeding with the delisting from Oslo, fits a patient, long-term view. The Oslo delisting is a non-cash, administrative process. As the company notes, it is supporting Tieto's simplification agenda and will be completed without interrupting trading on the Finnish and Swedish exchanges. For a value investor, the critical point is that this move does not alter the deployment of capital. The EUR 150 million buyback and the dividend payment are the real actions that affect shareholder value.

The board's rationale for maintaining the Stockholm listing-preserving visibility among Swedish investors and index inclusion-reflects an understanding of market structure. It suggests the company sees value in its Swedish investor base, which aligns with a strategy of steady, broad-based ownership rather than chasing short-term trading volume. The decision to keep the listing, despite the added complexity, implies the benefits of that visibility outweigh the costs. This is a classic trade-off in corporate governance: simplicity versus strategic access.

Financial Health and Profitability: A Turning Point

The company's financial health is showing clear signs of a turning point. The most telling metric is the adjusted operating margin (EBITA) up 3.8 percentage points to 16.2%. This expansion is not a one-off event but the result of a disciplined cost optimization program that is now delivering tangible results. The board has even uplifted the cost optimization target to EUR 130 million, signaling the program is executing ahead of schedule. For a value investor, this is the core of intrinsic value creation: improving the efficiency of the existing business engine.

This operational turnaround is reflected in the stock's valuation. The company's P/E ratio has improved from -30.8 at the end of 2024 to -10.5 as of April 2026. While still negative, this narrowing of the loss multiple is a critical step. It shows the market is beginning to price in a path toward sustained profitability, moving away from the deep skepticism of the prior year. The improvement suggests the cost savings are translating into earnings power, which is the foundation for long-term compounding.

The underlying business provides a stable base for this transformation. The company maintains a stable annual revenue base of approximately EUR 2 billion. This scale is important. It means the company is not chasing growth at any cost but is instead focusing on profitability within a predictable revenue stream. The recent quarterly results show a slight organic decline, but the margin expansion is more significant. It indicates the company is successfully navigating market headwinds by controlling its own costs.

The bottom line is that Tieto is moving from a period of losses to one of controlled profitability. The successful execution of the cost program, the narrowing valuation gap, and the stable revenue platform together form a setup for intrinsic value creation. For a patient investor, this is the kind of disciplined improvement that compounds over time. The focus now shifts to whether this margin expansion can be sustained and expanded as the company continues to simplify its portfolio.

Valuation and Forward-Looking Catalysts

The stock's current price sits near the midpoint of its recent trading range, a position that reflects a market in wait-and-see mode. With shares trading around EUR 18.90, they are just above the 52-week high of EUR 19.65 and well within the 52-week range of EUR 14.22 to 19.65. This aligns with the analyst consensus, which holds a Hold rating with a EUR 18.00 price target. The market is essentially pricing in a continuation of the current setup: a company showing clear operational improvement but still navigating headwinds in key verticals.

The primary catalyst for a re-rating is the successful execution of the company's dual-track strategy. The first leg is the ongoing cost optimization programme, which has already delivered a 3.8 percentage point expansion in the adjusted operating margin. The board's decision to uplift the target to EUR 130 million signals this program is on track. The second leg is the integration of strategic acquisitions, which are meant to support European expansion. If these initiatives continue to drive margin improvement and stabilize the revenue base, the path toward sustained profitability becomes clearer, justifying a higher valuation.

Key risks to this thesis remain. The company's organic growth was flat at -2%, pressured by continued market weakness in Tieto Banktech and Caretech. Any further deterioration in these segments could stall the margin gains. More broadly, the company must maintain the momentum of its profitability turnaround. The recent margin expansion is the foundation for intrinsic value, but it must be durable to support a permanent re-rating.

From a value perspective, the investment case is now in a validation phase. The financial trajectory is turning, with a narrowing valuation gap and a disciplined capital allocation plan in place. The stock's price near the 52-week midpoint suggests the market is waiting for concrete proof that the cost savings and integration efforts will translate into lasting earnings power. For a patient investor, the current price offers a chance to own a business in transition at a reasonable multiple, with the outcome hinging on the company's ability to execute its plan and navigate its cyclical headwinds.